Crossmark

Molecular analysis of cell survival and death pathways in the proteasome inhibitor bortezomib-resistant PC3 prostate cancer cell line

Published Online: 2021-08-07

Published Print: 2021-09

Authors

Kanbur, Ertan

Baykal, Ahmet Tarık

Yerlikaya, Azmi https://orcid.org/0000-0002-0678-0701
Funding

Funding for this research was provided by:

türkiye bilimsel ve teknolojik araştirma kurumu (119Z145)
License Information

Text and Data Mining valid from 2021-08-07

Version of Record valid from 2021-08-07
More Information

Article History

Received: 1 July 2021

Accepted: 2 August 2021

First Online: 7 August 2021

Declarations

:

: The authors declare that they have no conflict of interest in relation to the study.

Document is current